| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Blogging > User-Generated Content |
|
E-Folder - User-Generated Content
This review examines what impact web 2.0 type user generated content will have on business, providing links to some articles and a BBC According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product Radio 4 podcast that discuss this issue. The first article in this review of BBC articles on User Generated Content is this article by ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Professor Michael Geist of the University of Ottawa. An important recommendation Professor Geist makes on actions Government can take lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. relating to improving access to public research is this - "the introduction of open access requirements for publicly-funded research". here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ther content of the article is -"Internet law professor Michael Geist describes how governments can help their citizens make the most o d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro f the web. Time Magazine's choice late last month of "You" (by which it meant all the users generating content on the web) as the perso ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc n of the year was mocked by critics as a poor choice that by-passed several notable political leaders. Yet the choice may ultimately be easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi viewed as the tipping point when the remarkable outbreak of internet participation that encompasses millions of bloggers, music remixe nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s, amateur video creators, citizen journalists, wikipedians, and Flickr photographers broke into the mainstream." Professor Geist expla and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ins "the role of government will be to support the enormous economic and cultural potential of user-generated content, while avoiding s ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi teps that might impede its growth." How to help users help themselves - ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a 270593.stm">http://news.bbc.co.uk/1/hi/technology/6270593.stm. Other articles about user generated content are - BBC Technology n dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ws - Web users driving change in 2007 - http://news.bbc.co.uk/1/hi/technology/6198125.stm - Mark Ward Technology Correspondent - 1st Ja cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nuary 2007. 'You' named Time's person of 2006 - http://news.bbc.co.uk/1/hi/technology/6187113.stm - 17th December 2006. Below is a BB tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen C Radio 4 program (downloadable - listen again) that explains how the new approaches to open source and web software allowing user-gene t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel rated content is likely to affect business - BBC Radio 4 - New Wave Computing - ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust /inbusiness/inbusiness.shtml">http://www.bbc.co.uk/radio4/news/inbusiness/inbusiness.shtml - Peter Day talks to some of the rising y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products stars of the new revolution and finds out how the computer industry is changing yet again 11th January 2007. This report makes the cas . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e for increased use of open-source software - BBC Technology news - Open source gets European boost -http://news.bbc.co.uk/1/hi/techno elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip logy/6270657.stm - The European Commission has added its voice to the debate about the use of open source software. - 17th January 2007 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Customer Service for Chambers of Commerce Customer Service and Just in Time Distribution Conflicts
|